Why the UK was faster than US is race to approve Pfizer vaccine
Anthony Fauci apologises after suggesting Britain’s regulator ‘rushed’ process of assessing Covid jab
America’s top infectious diseases expert has apologised after apparently criticising the speed with which the UK approved the Pfizer vaccine to become the world’s first country to green-light the Covid immunity jab.
Dr Anthony Fauci, who heads the US National Institute of Allergy and Infectious Diseases, told CBS News yesterday that Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) had “really rushed through that approval”.
“I do have great faith in both the scientific community and the regulatory community in the UK,” Fauci continued. “I have a great deal of confidence in what the UK does both scientifically and from a regulatory standpoint.”
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The US medical chief held out the olive branch after the MHRA issued a statement insisting that it “rigorously assessed the data in the shortest time possible, without compromising the thoroughness of our review”.
The medicines regulator - which formally approved the Pfizer/BioNTech-developed jab on Wednesday - said its experts had reviewed preliminary data on the vaccine trials dating back to June and had been running a “rolling review” since October, helping to speed up the process.
The race to roll out a vaccine has generated “an extraordinary bout of global sniping”, with critics in both the US and European “taking aim at the MHRA for the speed with which it granted the vaccine an emergency authorisation”, The Times reports.
Experts say that the differences in approval timescales is down to “the US, EU and UK regulators [having] different styles”, the paper continues.
“While the Americans rerun the safety and efficacy analyses performed by drugmakers, the EU and UK check the analyses, which can be quicker.”
Fauci claims another reason for the US lagging behind is the strength of the opposition from anti-vaccination activists in the country. He told CBS: “If we had jumped over the hurdle here quickly and inappropriately to gain an extra week or a week and a half, I think that the credibility of our regulatory process would have been damaged.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
7 beautiful towns to visit in Switzerland during the holidays
The Week Recommends Find bliss in these charming Swiss locales that blend the traditional with the modern
By Catherine Garcia, The Week US Published
-
The Week contest: Werewolf bill
Puzzles and Quizzes
By The Week US Published
-
'This needs to be a bigger deal'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published